Skip to main content
R

Realcan Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 002589 LEI · 300300YI5IV3FBRRSJ48 Shenzhen Stock Exchange Wholesale and retail trade
Filings indexed 1,677 across all filing types
Latest filing 2025-09-22 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002589

About Realcan Pharmaceutical Group Co.,Ltd.

https://www.realcan.cn

Realcan Pharmaceutical Group Co., Ltd. specializes in the distribution of pharmaceutical products, medical devices, and healthcare consumables. The company operates an extensive supply chain network, providing integrated logistics and distribution services primarily to medical institutions and healthcare providers. Its core operations include the procurement, storage, and delivery of a wide range of medical supplies, supported by advanced information management systems and cold-chain logistics capabilities. Realcan also offers value-added services such as hospital supply chain optimization, third-party logistics, and financial solutions tailored to the healthcare industry. By focusing on a direct-to-hospital distribution model, the company aims to enhance the efficiency of medical supply procurement and ensure the timely delivery of critical healthcare products.

Recent filings

Filing Released Lang Actions
2025年第一次临时股东会决议的公告
Regulatory Filings
2025-09-22 Chinese
2025年第一次临时股东会的律师见证法律意见书
Regulatory Filings
2025-09-22 Chinese
关于持股5%以上股东股份减持计划实施完成的公告
Regulatory Filings
2025-09-08 Chinese
关于修订《公司章程》及部分治理制度的公告
Regulatory Filings
2025-09-05 Chinese
关于公司及子公司担保额度预计的公告
Regulatory Filings
2025-09-05 Chinese
董事会议事规则(二〇二五年九月)
Regulatory Filings
2025-09-05 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.